Table 1 Baseline characteristics of participants by randomised group: usual care (control) and the 3R intervention. Values are means (standard deviations) unless stated otherwise
Characteristics | Control (n = 107) | Intervention (n = 105) | All participants (n = 212) |
|---|---|---|---|
Age (years) | 63.9 (6.9) | 63.9 (7.5) | 63.9 (7.2) |
Ethnicity (no. (%)) | |||
 White | 104 (97) | 102 (97) | 206 (97) |
 Others | 3 (3) | 3 (3) | 6 (3) |
No. (%) women | 58 (54) | 56 (53) | 114 (54) |
No. (%) men | 49 (46) | 49 (47) | 98 (46) |
Smoking status (no. (%)) | |||
 Current | 8 (7) | 5 (5) | 13 (6) |
 Former | 50 (47) | 47 (45) | 97 (46) |
 Never | 49 (46) | 53 (51) | 102 (48) |
Risk of CVD in next 10 years (mean % (SD)) | 16 (7.6) | 16 (9.4) | 16.2 (8.5) |
Comorbidities (median (interquartile range)) | 2 (1–3) | 2 (1–3) | 2 (1–3) |
Biometric measurements | |||
 Body weight (kg) | 81.2 (18.4) | 81.5 (17.4) | 81.3 (17.9) |
 Body mass index (kg/m2) | 28.9 (5.1) | 28.8 (4.7) | 28.9 (5.0) |
 Waist circumference (cm) | 97.3 (13.4) | 98.5 (13.0) | 97.9 (13.2) |
 Hip circumference (cm) | 106.5 (11.5) | 106.2 (9.4) | 106.3 (10.5) |
 Waist-to-hip ratio | 0.9 (0.1) | 0.9 (0.1) | 0.9 (0.1) |
 Systolic blood pressure (mmHg) | 142.0 (18.0) | 139.3 (18.1) | 140.7 (18.1) |
 Diastolic blood pressure (mmHg) | 87.4 (10.0) | 86.1 (10.9) | 86.8 (10.4) |
Adherences to statins variables | |||
 Urine test for statin adherence (no. (%)) | 33 (47) | 40 (62) | 73 (54) |
 MMAS* score = 8 for high adherence (no. (%)) | 35 (33) | 32 (30) | 67 (32) |
 Total cholesterol (mmol/l) | 5.8 (0.8) | 5.9 (0.8) | 5.9 (0.8) |
 High density lipoprotein cholesterol (mmol/l) | 1.7 (0.6) | 1.6 (0.5) | 1.7 (0.5) |
 TC:HDL ratio | 3.9 (1.3) | 3.9 (1.4) | 3.9 (1.3) |
 No. of years on statins prior to enrolment mean (range) | 8.0 (1.2–20.8) | 8.3 (1.1–20.6) | 8.2 (1.1–20.8) |